Maggiori informazioni sul libro
Sixty contributions on liposomes and their uses in drug delivery. Conventional use of drugs suffers from indiscriminate drug action leading to side effects; failure of drugs to reach areas in need of pharmacological intervention; and premature drug inactivation and secretion. This book describes how liposomes incorporating drugs can direct these to diseased areas (in isolation from non-target biological areas) and introduce drugs to areas otherwise inaccessible. Discusses the interaction of liposomes with the biological milieu in vitro and in vivo , ways of optimizing liposomal behavior by manipulation of the carrier, applications related to antimicrobial and cancer therapy, vaccines, enzyme therapy, metal detoxification, diagnostics, and more.
Acquisto del libro
Liposomes as Drug Carriers, Gregory Gregoriadis
- Lingua
- Pubblicato
- 1988
- product-detail.submit-box.info.binding
- (Copertina rigida)
Metodi di pagamento
Ancora nessuna valutazione.
- Titolo
- Liposomes as Drug Carriers
- Sottotitolo
- Recent Trends and Progress
- Lingua
- Inglese
- Autori
- Gregory Gregoriadis
- Editore
- Wiley
- Pubblicato
- 1988
- Formato
- Copertina rigida
- Pagine
- 910
- ISBN10
- 0471916544
- ISBN13
- 9780471916543
- Serie
- Tag
- Medicina, Farmacologia
- Descrizione
- Sixty contributions on liposomes and their uses in drug delivery. Conventional use of drugs suffers from indiscriminate drug action leading to side effects; failure of drugs to reach areas in need of pharmacological intervention; and premature drug inactivation and secretion. This book describes how liposomes incorporating drugs can direct these to diseased areas (in isolation from non-target biological areas) and introduce drugs to areas otherwise inaccessible. Discusses the interaction of liposomes with the biological milieu in vitro and in vivo , ways of optimizing liposomal behavior by manipulation of the carrier, applications related to antimicrobial and cancer therapy, vaccines, enzyme therapy, metal detoxification, diagnostics, and more.